Literature DB >> 22983839

Narrow band imaging versus white light gastroscopy in detecting potentially premalignant gastric lesions: a randomized prospective crossover study.

Amit Kumar Dutta1, Kattiparambil Gangadharan Sajith, Anna Benjamin Pulimood, Ashok Chacko.   

Abstract

BACKGROUND AND AIMS: Narrow band imaging (NBI) detects mucosal surface details (pit pattern) as well as the microvasculature pattern of mucosa. In premalignant conditions the pattern and regularity of pits and microvasculature are altered. We aimed to assess whether NBI is superior to conventional white light gastroscopy (WLG) in detecting potentially premalignant gastric lesions. PATIENTS AND METHODS: We conducted a randomized prospective crossover study from January 2009 to July 2009. Patients above 45 years of age with dyspepsia in absence of alarm symptoms underwent gastric mucosal examination using WLG and NBI in the same session by different endoscopists who were blinded to each other's endoscopy findings. Biopsy was taken if required at the end of the second gastroscopy after a third observer reviewed reports of both scopists. The yield of gastric potentially premalignant lesions (atrophic gastritis, intestinal metaplasia, dysplasia, adenomatous polyp) was compared for both procedures.
RESULTS: Two hundred [mean age 52.3 (6.4) years, males-66 %] patients participated in the study. Thirty-two patients were diagnosed to have potentially premalignant lesions using both modalities. No patient had early gastric cancer. WLG detected lesions in 17 patients (atrophic gastritis in 12, atrophic gastritis with intestinal metaplasia in 5) and NBI in 31 patients (atrophic gastritis in 22, atrophic gastritis with intestinal metaplasia in 9). The sensitivity of lesion detection by NBI was significantly higher than WLG (p = 0.001).
CONCLUSIONS: NBI was superior to WLG for detection of atrophic gastritis and intestinal metaplasia.

Entities:  

Mesh:

Year:  2012        PMID: 22983839     DOI: 10.1007/s12664-012-0246-5

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  34 in total

1.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 2.  AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.

Authors:  N J Talley; M D Silverstein; L Agréus; O Nyrén; A Sonnenberg; G Holtmann
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

3.  Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55?

Authors:  D Gillen; K E McColl
Journal:  Am J Gastroenterol       Date:  1999-01       Impact factor: 10.864

4.  Clinical and endoscopic characterization of depressed gastric adenoma.

Authors:  N Tamai; M Kaise; T Nakayoshi; M Katoh; K Sumiyama; K Gohda; T Yamasaki; H Arakawa; H Tajiri
Journal:  Endoscopy       Date:  2006-04       Impact factor: 10.093

5.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

6.  Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study.

Authors:  M B Wallace; V L Durkalski; J Vaughan; Y Y Palesch; E D Libby; P S Jowell; N J Nickl; S M Schutz; J W Leung; P B Cotton
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 7.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

8.  Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia.

Authors:  N P Breslin; A B Thomson; R J Bailey; P K Blustein; J Meddings; E Lalor; G M VanRosendaal; M J Verhoef; L R Sutherland
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 9.  Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool.

Authors:  Sander J O Veldhuyzen van Zanten; Marc Bradette; Naoki Chiba; David Armstrong; Alan Barkun; Nigel Flook; Alan Thomson; Ford Bursey
Journal:  Can J Gastroenterol       Date:  2005-05       Impact factor: 3.522

10.  The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study.

Authors:  Anne Mette Asfeldt; Sonja Eriksson Steigen; Maja-Lisa Løchen; Bjørn Straume; Roar Johnsen; Bjørn Bernersen; Jon Florholmen; Eyvind J Paulssen
Journal:  Eur J Epidemiol       Date:  2009-07-21       Impact factor: 8.082

View more
  10 in total

1.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Authors:  Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro
Journal:  Gut       Date:  2019-07-05       Impact factor: 23.059

2.  Magnified and enhanced computed virtual chromoendoscopy in gastric neoplasia: a feasibility study.

Authors:  Chang-Qing Li; Ya Li; Xiu-Li Zuo; Rui Ji; Zhen Li; Xiao-Meng Gu; Tao Yu; Qing-Qing Qi; Cheng-Jun Zhou; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

Review 3.  Evidence based review of the impact of image enhanced endoscopy in the diagnosis of gastric disorders.

Authors:  Ikram Hussain; Tiing Leong Ang
Journal:  World J Gastrointest Endosc       Date:  2016-12-16

Review 4.  The evolving role of endoscopy in the diagnosis of premalignant gastric lesions.

Authors:  William Waddingham; David Graham; Matthew Banks; Marnix Jansen
Journal:  F1000Res       Date:  2018-06-08

5.  Diagnostic value of linked color imaging based on endoscopy for gastric intestinal metaplasia: a systematic review and meta-analysis.

Authors:  Xiaochuang Shu; Guozhi Wu; Yanjun Zhang; Yuping Wang; Ya Zheng; Qinghong Guo; Rui Ji; Yongning Zhou
Journal:  Ann Transl Med       Date:  2021-03

Review 6.  Proposal of minimum elements for screening and diagnosis of gastric cancer by an international Delphi consensus.

Authors:  Naomi Kakushima; Mitsuhiro Fujishiro; Shannon Melissa Chan; George Adel Cortas; Mario Dinis-Ribeiro; Robinson Gonzalez; Shinya Kodashima; Sun-Young Lee; Enqiang Linghu; Katsuhiro Mabe; Wensheng Pan; Adolfo Parra-Blanco; Mathieu Pioche; Antonio Rollan; Kazuki Sumiyama; Miguel Tanimoto
Journal:  DEN open       Date:  2022-02-24

7.  Expert-level classification of gastritis by endoscopy using deep learning: a multicenter diagnostic trial.

Authors:  Ganggang Mu; Yijie Zhu; Zhanyue Niu; Hongyan Li; Lianlian Wu; Jing Wang; Renquan Luo; Xiao Hu; Yanxia Li; Jixiang Zhang; Shan Hu; Chao Li; Shigang Ding; Honggang Yu
Journal:  Endosc Int Open       Date:  2021-05-27

Review 8.  Recent advances in the detection and management of early gastric cancer and its precursors.

Authors:  William Waddingham; Stella A V Nieuwenburg; Sean Carlson; Manuel Rodriguez-Justo; Manon Spaander; Ernst J Kuipers; Marnix Jansen; David G Graham; Matthew Banks
Journal:  Frontline Gastroenterol       Date:  2020-07-30

9.  Recent advances in diagnostic upper endoscopy.

Authors:  Jun-Liang Teh; Asim Shabbir; Soon Yuen; Jimmy Bok-Yan So
Journal:  World J Gastroenterol       Date:  2020-01-28       Impact factor: 5.742

Review 10.  Usefulness of artificial intelligence in gastric neoplasms.

Authors:  Ji Hyun Kim; Seung-Joo Nam; Sung Chul Park
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.